Andrew P Cap

InstitutionJoint Trauma System
AddressTexas
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 2 publications in July 2021
    All Publications
    Bar chart showing 164 publications over 15 distinct years, with a maximum of 28 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Citations:    Fields:    Translation:HumansPHPublic Health
    2. Pati S, Fennern E, Holcomb JB, Barry M, Trivedi A, Cap AP, Martin MJ, Wade C, Kozar R, Cardenas JC, Rappold JF, Spiegel R, Schreiber MA. Treating the endotheliopathy of SARS-CoV-2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products. Transfusion. 2021 07; 61 Suppl 1:S336-S347. PMID: 34269437.
      Citations: 1     Fields:    Translation:Humans
    3. O'Rourke B, Nguyen S, Tilles AW, Bynum JA, Cap AP, Parekkadan B, Barcia RN. Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application. Stem Cells Transl Med. 2021 06; 10(6):883-894. PMID: 33527780.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    4. Hightower S, Ellis H, Collen J, Ellis J, Grasso I, Roswarski J, Cap AP, Chung K, Prescher L, Kavanaugh M, Brown T, Nau M, Clark P. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019. Thromb Res. 2020 11; 195:69-71. PMID: 32659463.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    5. Wright Z, Bersabe A, Eden R, Bradley J, Cap A. Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma. Clin Lymphoma Myeloma Leuk. 2021 01; 21(1):66-68. PMID: 32682684.
      Citations: 8     Fields:    Translation:Humans